Loading...
Keywords
Last Name
Institution

Connection

Tarak Srivastava to Calcimimetic Agents

This is a "connection" page, showing publications Tarak Srivastava has written about Calcimimetic Agents.

 
Connection Strength
 
 
 
1.890
 
  1. Srivastava T, Jafri S, Truog WE, Sebestyen VanSickle J, Manimtim WM, Alon US. Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet. Pediatrics. 2017 Dec; 140(6).
    View in: PubMed
    Score: 0.612
  2. Alon US, Jarka D, Monachino PJ, Sebestyen VanSickle J, Srivastava T. Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphataemic rickets. Clin Endocrinol (Oxf). 2017 07; 87(1):114-116.
    View in: PubMed
    Score: 0.588
  3. Srivastava T, Krudys J, Mardis NJ, Sebestyen-VanSickle J, Alon US. Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b. Pediatr Nephrol. 2016 May; 31(5):795-800.
    View in: PubMed
    Score: 0.533
  4. VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.
    View in: PubMed
    Score: 0.156
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.